In early 2028, pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will likely be a larger and more diversified business, assuming its foray into primary care goes according to plan. The pharmacy company finds itself in the midst of an attempt to diversify into providing healthcare services like primary care during a time when its top and bottom lines are looking somewhat weak. As you can see, both its quarterly revenue and net income haven't shown much sign of improvement over the last five years.